- Home
- ELEV vs MASK Comparison
ELEV vs MASK Comparison
Compare ELEV & MASK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- MASK
- Stock Information
- Founded
- ELEV 2019
- MASK 2017
- Country
- ELEV United States
- MASK China
- Employees
- ELEV N/A
- MASK N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- MASK
- Sector
- ELEV Health Care
- MASK
- Exchange
- ELEV Nasdaq
- MASK NYSE
- Market Cap
- ELEV 22.0M
- MASK 38.3M
- IPO Year
- ELEV 2021
- MASK 2025
- Fundamental
- Price
- ELEV $0.36
- MASK $3.35
- Analyst Decision
- ELEV Buy
- MASK
- Analyst Count
- ELEV 6
- MASK 0
- Target Price
- ELEV $2.94
- MASK N/A
- AVG Volume (30 Days)
- ELEV 996.3K
- MASK 32.5K
- Earning Date
- ELEV 05-16-2025
- MASK 01-01-0001
- Dividend Yield
- ELEV N/A
- MASK N/A
- EPS Growth
- ELEV N/A
- MASK 12.16
- EPS
- ELEV N/A
- MASK 0.19
- Revenue
- ELEV N/A
- MASK $4,718,055.00
- Revenue This Year
- ELEV N/A
- MASK N/A
- Revenue Next Year
- ELEV N/A
- MASK N/A
- P/E Ratio
- ELEV N/A
- MASK $16.60
- Revenue Growth
- ELEV N/A
- MASK 7.89
- 52 Week Low
- ELEV $0.22
- MASK $2.50
- 52 Week High
- ELEV $4.33
- MASK $4.19
- Technical
- Relative Strength Index (RSI)
- ELEV 52.69
- MASK N/A
- Support Level
- ELEV $0.34
- MASK N/A
- Resistance Level
- ELEV $0.36
- MASK N/A
- Average True Range (ATR)
- ELEV 0.03
- MASK 0.00
- MACD
- ELEV 0.00
- MASK 0.00
- Stochastic Oscillator
- ELEV 50.00
- MASK 0.00
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.
About MASK 3 E NETWORK TECHNOLOGY GROUP LTD
3 E Network Technology Group Ltd is a business-to-business (B2B) information technology (IT) business solutions provider. It focuses on integrated software and hardware solutions in the property management and exhibition services spaces and expanded software solutions offering to a variety of industries and sectors, including food establishments, real estate, exhibition & conferencing, and clean energy utilities. The business includes two main portfolios, namely the software development portfolio and exhibition and conference portfolio. Maximum revenue is generated from the software development portfolio.